Victoria Hull Sells 2,777 Shares of Hikma Pharmaceuticals PLC (LON:HIK) Stock

Hikma Pharmaceuticals PLC (LON:HIKGet Free Report) insider Victoria Hull sold 2,777 shares of the company’s stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of GBX 1,800 ($22.91), for a total transaction of £49,986 ($63,627.80).

Hikma Pharmaceuticals Stock Up 2.6 %

Shares of LON HIK traded up GBX 47 ($0.60) during mid-day trading on Tuesday, reaching GBX 1,841 ($23.43). The company had a trading volume of 552,782 shares, compared to its average volume of 1,700,715. Hikma Pharmaceuticals PLC has a 52-week low of GBX 1,750 ($22.28) and a 52-week high of GBX 2,360 ($30.04). The stock has a market cap of £5.11 billion, a P/E ratio of 18.07, a PEG ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82. The firm has a 50 day simple moving average of GBX 2,148.46 and a two-hundred day simple moving average of GBX 2,016.29.

Hikma Pharmaceuticals Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, May 1st. Stockholders of record on Thursday, March 20th will be issued a $0.48 dividend. This represents a dividend yield of 1.8%. This is a boost from Hikma Pharmaceuticals’s previous dividend of $0.32. The ex-dividend date of this dividend is Thursday, March 20th. Hikma Pharmaceuticals’s dividend payout ratio is presently 60.84%.

Analysts Set New Price Targets

HIK has been the subject of several research analyst reports. JPMorgan Chase & Co. restated an “overweight” rating on shares of Hikma Pharmaceuticals in a research report on Friday, March 7th. Berenberg Bank restated a “buy” rating and set a GBX 2,560 ($32.59) target price on shares of Hikma Pharmaceuticals in a report on Monday, March 10th.

Get Our Latest Stock Analysis on HIK

Hikma Pharmaceuticals Company Profile

(Get Free Report)

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.

Featured Stories

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.